Note: Ingredients listed on restricted chemical lists
EC/CAS
200-338-0/57-55-6
Name of the chemical
1,2-propanediol
Concentration
N/A
EC/CAS
254-372-6/39236-46-9
Name of the chemical
N,N″-methylenebis[N′-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea]
Concentration
N/A
General Information
Revision date
2020-05-22
Product name
CUTIVATE CREAM
Product Synonyms
CUTIVATE CREAM 0.05% W/W (ANZ) * CUTIVATE CREAM (0.05%) 15g (ANZ) * CUTIVATE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Section 2
EU Classification
Regulation (EC) No 1272/2008 as amended This mixture does not meet the criteria for classification according to Regulation (EC) 1272/2008 as amended. Hazard summary This product will support combustion at elevated temperatures. Caution - Pharmaceutical agent. May cause sensitisation by skin contact. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
FLUTICASONE PROPIONATE, HYDROUS CITRIC ACID, ISOPROPYL MYRISTATE, LIGHT MINERAL OIL, Propylene glycol
Hazard pictograms
None.
Signal word
None.
Hazard statements
The mixture does not meet the criteria for classification.
Prevention
Not available.
Response
Not available.
Storage
Not available.
Disposal
Not available.
Supplemental label elements
40 % of the mixture consists of component(s) of unknown acute dermal toxicity. 40 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 40 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 40 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. EUH208 - Contains IMIDUREA. May produce an allergic reaction.
2.3 Other hazards
This product will support combustion at elevated temperatures. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.